context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
PHI excludes cash of $ 96 million and $ 165 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. Pepco excludes cash of $ 48 million and $ 45 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. DPL excludes cash of $ 15 million and $ 31 million at December 31, 2023 and 2022, respectively. ACE excludes cash of $ 21 million and $ 71 million at December 31, 2023 and 2022, respectively. | text | 21 | monetaryItemType | text: <entity> 21 </entity> <entity type> monetaryItemType </entity type> <context> PHI excludes cash of $ 96 million and $ 165 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. Pepco excludes cash of $ 48 million and $ 45 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. DPL excludes cash of $ 15 million and $ 31 million at December 31, 2023 and 2022, respectively. ACE excludes cash of $ 21 million and $ 71 million at December 31, 2023 and 2022, respectively. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
PHI excludes cash of $ 96 million and $ 165 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. Pepco excludes cash of $ 48 million and $ 45 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. DPL excludes cash of $ 15 million and $ 31 million at December 31, 2023 and 2022, respectively. ACE excludes cash of $ 21 million and $ 71 million at December 31, 2023 and 2022, respectively. | text | 71 | monetaryItemType | text: <entity> 71 </entity> <entity type> monetaryItemType </entity type> <context> PHI excludes cash of $ 96 million and $ 165 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. Pepco excludes cash of $ 48 million and $ 45 million at December 31, 2023 and 2022, respectively, and restricted cash of $ 1 million and $ 3 million at December 31, 2023 and 2022, respectively. DPL excludes cash of $ 15 million and $ 31 million at December 31, 2023 and 2022, respectively. ACE excludes cash of $ 21 million and $ 71 million at December 31, 2023 and 2022, respectively. </context> | us-gaap:CashAndCashEquivalentsFairValueDisclosure |
Includes $ 83 million of decreases in fair value and an increase for realized gains due to settlements of $ 34 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the year ended December 31, 2023. Includes $ 136 million of increases in fair value and a decrease for realized losses due to settlements of $ 1 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the year ended December 31, 2022. | text | 83 | monetaryItemType | text: <entity> 83 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 83 million of decreases in fair value and an increase for realized gains due to settlements of $ 34 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the year ended December 31, 2023. Includes $ 136 million of increases in fair value and a decrease for realized losses due to settlements of $ 1 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the year ended December 31, 2022. </context> | us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease |
Includes $ 83 million of decreases in fair value and an increase for realized gains due to settlements of $ 34 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the year ended December 31, 2023. Includes $ 136 million of increases in fair value and a decrease for realized losses due to settlements of $ 1 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the year ended December 31, 2022. | text | 34 | monetaryItemType | text: <entity> 34 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 83 million of decreases in fair value and an increase for realized gains due to settlements of $ 34 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the year ended December 31, 2023. Includes $ 136 million of increases in fair value and a decrease for realized losses due to settlements of $ 1 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the year ended December 31, 2022. </context> | us-gaap:RealizedInvestmentGainsLosses |
Includes $ 83 million of decreases in fair value and an increase for realized gains due to settlements of $ 34 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the year ended December 31, 2023. Includes $ 136 million of increases in fair value and a decrease for realized losses due to settlements of $ 1 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the year ended December 31, 2022. | text | 136 | monetaryItemType | text: <entity> 136 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 83 million of decreases in fair value and an increase for realized gains due to settlements of $ 34 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the year ended December 31, 2023. Includes $ 136 million of increases in fair value and a decrease for realized losses due to settlements of $ 1 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the year ended December 31, 2022. </context> | us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease |
Includes $ 83 million of decreases in fair value and an increase for realized gains due to settlements of $ 34 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the year ended December 31, 2023. Includes $ 136 million of increases in fair value and a decrease for realized losses due to settlements of $ 1 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the year ended December 31, 2022. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 83 million of decreases in fair value and an increase for realized gains due to settlements of $ 34 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the year ended December 31, 2023. Includes $ 136 million of increases in fair value and a decrease for realized losses due to settlements of $ 1 million recorded in Purchased power expense associated with floating-to-fixed energy swap contracts with unaffiliated suppliers for the year ended December 31, 2022. </context> | us-gaap:RealizedInvestmentGainsLosses |
The balance of the current and noncurrent asset was effectively zero as of December 31, 2023. The balance consists of a current and noncurrent liability of $ 27 million and $ 106 million, respectively, as of December 31, 2023. | text | zero | monetaryItemType | text: <entity> zero </entity> <entity type> monetaryItemType </entity type> <context> The balance of the current and noncurrent asset was effectively zero as of December 31, 2023. The balance consists of a current and noncurrent liability of $ 27 million and $ 106 million, respectively, as of December 31, 2023. </context> | us-gaap:DerivativeAssets |
The balance of the current and noncurrent asset was effectively zero as of December 31, 2023. The balance consists of a current and noncurrent liability of $ 27 million and $ 106 million, respectively, as of December 31, 2023. | text | 27 | monetaryItemType | text: <entity> 27 </entity> <entity type> monetaryItemType </entity type> <context> The balance of the current and noncurrent asset was effectively zero as of December 31, 2023. The balance consists of a current and noncurrent liability of $ 27 million and $ 106 million, respectively, as of December 31, 2023. </context> | us-gaap:DerivativeLiabilitiesCurrent |
The balance of the current and noncurrent asset was effectively zero as of December 31, 2023. The balance consists of a current and noncurrent liability of $ 27 million and $ 106 million, respectively, as of December 31, 2023. | text | 106 | monetaryItemType | text: <entity> 106 </entity> <entity type> monetaryItemType </entity type> <context> The balance of the current and noncurrent asset was effectively zero as of December 31, 2023. The balance consists of a current and noncurrent liability of $ 27 million and $ 106 million, respectively, as of December 31, 2023. </context> | us-gaap:DerivativeLiabilitiesNoncurrent |
Represents the maximum potential obligation in the event that the fair value of certain leased equipment and fleet vehicles is zero at the end of the maximum lease term. The lease term associated with these assets ranges from 1 to 8 years. The maximum potential obligation at the end of the minimum lease term would be $ 61 million guaranteed by Exelon and PHI, of which $ 20 million | text | 20 | monetaryItemType | text: <entity> 20 </entity> <entity type> monetaryItemType </entity type> <context> Represents the maximum potential obligation in the event that the fair value of certain leased equipment and fleet vehicles is zero at the end of the maximum lease term. The lease term associated with these assets ranges from 1 to 8 years. The maximum potential obligation at the end of the minimum lease term would be $ 61 million guaranteed by Exelon and PHI, of which $ 20 million </context> | us-gaap:GuaranteeObligationsMaximumExposure |
$ 24 million, and $ 17 million is guaranteed by Pepco, DPL, and ACE, respectively. Historically, payments under the guarantees have not been made and PHI believes the likelihood of payments being required under the guarantees is remote. | text | 24 | monetaryItemType | text: <entity> 24 </entity> <entity type> monetaryItemType </entity type> <context> $ 24 million, and $ 17 million is guaranteed by Pepco, DPL, and ACE, respectively. Historically, payments under the guarantees have not been made and PHI believes the likelihood of payments being required under the guarantees is remote. </context> | us-gaap:GuaranteeObligationsMaximumExposure |
$ 24 million, and $ 17 million is guaranteed by Pepco, DPL, and ACE, respectively. Historically, payments under the guarantees have not been made and PHI believes the likelihood of payments being required under the guarantees is remote. | text | 17 | monetaryItemType | text: <entity> 17 </entity> <entity type> monetaryItemType </entity type> <context> $ 24 million, and $ 17 million is guaranteed by Pepco, DPL, and ACE, respectively. Historically, payments under the guarantees have not been made and PHI believes the likelihood of payments being required under the guarantees is remote. </context> | us-gaap:GuaranteeObligationsMaximumExposure |
In 2023, ComEd and PECO completed an annual study of their future estimated MGP remediation requirements. The study resulted in a $ 25 million increase to the environmental liability and related regulatory asset for ComEd. | text | 25 | monetaryItemType | text: <entity> 25 </entity> <entity type> monetaryItemType </entity type> <context> In 2023, ComEd and PECO completed an annual study of their future estimated MGP remediation requirements. The study resulted in a $ 25 million increase to the environmental liability and related regulatory asset for ComEd. </context> | us-gaap:AccrualForEnvironmentalLossContingenciesPeriodIncreaseDecrease |
On September 28, 2023, Exelon and ComEd reached a settlement with the SEC, concluding and resolving in its entirety the SEC investigation, which related to the conduct identified in the DPA that was entered into by ComEd in July 2020 and successfully exited in July 2023. Under the terms of the settlement, Exelon agreed to pay a civil penalty of $ 46.2 million and Exelon and ComEd agreed to cease and desist from committing or causing any violations and any future violations of specified provisions of the federal securities laws and rules promulgated thereunder. Exelon recorded an accrual for the full amount of the penalty in the second quarter of 2023, which was reflected in Operating and maintenance expense within Exelon's Consolidated Statements of Operations and Comprehensive Income and in Accrued expenses on the Consolidated Balance Sheets. Exelon paid the civil penalty in full on October 4, 2023. | text | 46.2 | monetaryItemType | text: <entity> 46.2 </entity> <entity type> monetaryItemType </entity type> <context> On September 28, 2023, Exelon and ComEd reached a settlement with the SEC, concluding and resolving in its entirety the SEC investigation, which related to the conduct identified in the DPA that was entered into by ComEd in July 2020 and successfully exited in July 2023. Under the terms of the settlement, Exelon agreed to pay a civil penalty of $ 46.2 million and Exelon and ComEd agreed to cease and desist from committing or causing any violations and any future violations of specified provisions of the federal securities laws and rules promulgated thereunder. Exelon recorded an accrual for the full amount of the penalty in the second quarter of 2023, which was reflected in Operating and maintenance expense within Exelon's Consolidated Statements of Operations and Comprehensive Income and in Accrued expenses on the Consolidated Balance Sheets. Exelon paid the civil penalty in full on October 4, 2023. </context> | us-gaap:LossContingencyAccrualAtCarryingValue |
In August 2022, the ICC concluded its investigation initiated on August 12, 2021 into rate impacts of conduct admitted in the DPA, including the costs recovered from customers related to the DPA and Exelon's funding of the fine paid by ComEd. On August 17, 2022, the ICC issued its final order accepting ComEd's voluntary customer refund offer of approximately $ 38 million (of which about $ 31 million is ICC jurisdictional; the remaining balance is FERC jurisdictional) that resolves the question of whether customer funds were used for DPA related activities. The customer refund includes the cost of every individual or entity that was either (i) identified in the DPA or (ii) identified by ComEd as an associate of the former Speaker of the Illinois House of Representatives in the ICC proceeding. The ICC’s DPA investigation is now closed. The ICC jurisdictional refund was made to customers during the April 2023 billing cycle, as required by the ICC. The FERC jurisdictional refund was included in ComEd's transmission formula rate update proceeding, filed on May 12, 2023. The filed transmission rate, inclusive of the FERC jurisdictional DPA refund, will appear on ComEd retail customers' bills for the June 2023 through May 2024 monthly billing periods, in the line designated as "Transmission Services Charge." The customer refund will not be recovered in rates or charged to customers and ComEd will not seek or accept reimbursement or indemnification from any source other than Exelon. An accrual for the amount of the customer refund has been recorded in Regulatory assets in Exelon’s and ComEd’s Consolidated Balance Sheets as of December 31, 2023. | text | 38 | monetaryItemType | text: <entity> 38 </entity> <entity type> monetaryItemType </entity type> <context> In August 2022, the ICC concluded its investigation initiated on August 12, 2021 into rate impacts of conduct admitted in the DPA, including the costs recovered from customers related to the DPA and Exelon's funding of the fine paid by ComEd. On August 17, 2022, the ICC issued its final order accepting ComEd's voluntary customer refund offer of approximately $ 38 million (of which about $ 31 million is ICC jurisdictional; the remaining balance is FERC jurisdictional) that resolves the question of whether customer funds were used for DPA related activities. The customer refund includes the cost of every individual or entity that was either (i) identified in the DPA or (ii) identified by ComEd as an associate of the former Speaker of the Illinois House of Representatives in the ICC proceeding. The ICC’s DPA investigation is now closed. The ICC jurisdictional refund was made to customers during the April 2023 billing cycle, as required by the ICC. The FERC jurisdictional refund was included in ComEd's transmission formula rate update proceeding, filed on May 12, 2023. The filed transmission rate, inclusive of the FERC jurisdictional DPA refund, will appear on ComEd retail customers' bills for the June 2023 through May 2024 monthly billing periods, in the line designated as "Transmission Services Charge." The customer refund will not be recovered in rates or charged to customers and ComEd will not seek or accept reimbursement or indemnification from any source other than Exelon. An accrual for the amount of the customer refund has been recorded in Regulatory assets in Exelon’s and ComEd’s Consolidated Balance Sheets as of December 31, 2023. </context> | us-gaap:CustomerRefundLiabilityCurrent |
In August 2022, the ICC concluded its investigation initiated on August 12, 2021 into rate impacts of conduct admitted in the DPA, including the costs recovered from customers related to the DPA and Exelon's funding of the fine paid by ComEd. On August 17, 2022, the ICC issued its final order accepting ComEd's voluntary customer refund offer of approximately $ 38 million (of which about $ 31 million is ICC jurisdictional; the remaining balance is FERC jurisdictional) that resolves the question of whether customer funds were used for DPA related activities. The customer refund includes the cost of every individual or entity that was either (i) identified in the DPA or (ii) identified by ComEd as an associate of the former Speaker of the Illinois House of Representatives in the ICC proceeding. The ICC’s DPA investigation is now closed. The ICC jurisdictional refund was made to customers during the April 2023 billing cycle, as required by the ICC. The FERC jurisdictional refund was included in ComEd's transmission formula rate update proceeding, filed on May 12, 2023. The filed transmission rate, inclusive of the FERC jurisdictional DPA refund, will appear on ComEd retail customers' bills for the June 2023 through May 2024 monthly billing periods, in the line designated as "Transmission Services Charge." The customer refund will not be recovered in rates or charged to customers and ComEd will not seek or accept reimbursement or indemnification from any source other than Exelon. An accrual for the amount of the customer refund has been recorded in Regulatory assets in Exelon’s and ComEd’s Consolidated Balance Sheets as of December 31, 2023. | text | 31 | monetaryItemType | text: <entity> 31 </entity> <entity type> monetaryItemType </entity type> <context> In August 2022, the ICC concluded its investigation initiated on August 12, 2021 into rate impacts of conduct admitted in the DPA, including the costs recovered from customers related to the DPA and Exelon's funding of the fine paid by ComEd. On August 17, 2022, the ICC issued its final order accepting ComEd's voluntary customer refund offer of approximately $ 38 million (of which about $ 31 million is ICC jurisdictional; the remaining balance is FERC jurisdictional) that resolves the question of whether customer funds were used for DPA related activities. The customer refund includes the cost of every individual or entity that was either (i) identified in the DPA or (ii) identified by ComEd as an associate of the former Speaker of the Illinois House of Representatives in the ICC proceeding. The ICC’s DPA investigation is now closed. The ICC jurisdictional refund was made to customers during the April 2023 billing cycle, as required by the ICC. The FERC jurisdictional refund was included in ComEd's transmission formula rate update proceeding, filed on May 12, 2023. The filed transmission rate, inclusive of the FERC jurisdictional DPA refund, will appear on ComEd retail customers' bills for the June 2023 through May 2024 monthly billing periods, in the line designated as "Transmission Services Charge." The customer refund will not be recovered in rates or charged to customers and ComEd will not seek or accept reimbursement or indemnification from any source other than Exelon. An accrual for the amount of the customer refund has been recorded in Regulatory assets in Exelon’s and ComEd’s Consolidated Balance Sheets as of December 31, 2023. </context> | us-gaap:CustomerRefundLiabilityCurrent |
On August 4, 2022, Exelon entered into an agreement with certain underwriters in connection with an underwritten public offering (the “Offering”) of 11.3 million shares (the “Shares”) of its Common stock, no par value (“Common Stock”). The Shares were sold to the underwriters at a price per share of $ 43.32 . Exelon also granted the underwriters an option to purchase an additional 1.695 million shares of Common stock also at the price per share of $ 43.32 . On August 5, 2022, the underwriters exercised the option in full. The net proceeds from the Offering and the exercise of the underwriters’ option were $ 563 million before expenses paid by Exelon. Exelon used the proceeds, together with available cash balances, to repay $ 575 million in borrowings under a $ 1.15 billion term loan credit facility. See Note 16 — Debt and Credit Agreements for additional information on Exelon’s term loan. | text | 11.3 | sharesItemType | text: <entity> 11.3 </entity> <entity type> sharesItemType </entity type> <context> On August 4, 2022, Exelon entered into an agreement with certain underwriters in connection with an underwritten public offering (the “Offering”) of 11.3 million shares (the “Shares”) of its Common stock, no par value (“Common Stock”). The Shares were sold to the underwriters at a price per share of $ 43.32 . Exelon also granted the underwriters an option to purchase an additional 1.695 million shares of Common stock also at the price per share of $ 43.32 . On August 5, 2022, the underwriters exercised the option in full. The net proceeds from the Offering and the exercise of the underwriters’ option were $ 563 million before expenses paid by Exelon. Exelon used the proceeds, together with available cash balances, to repay $ 575 million in borrowings under a $ 1.15 billion term loan credit facility. See Note 16 — Debt and Credit Agreements for additional information on Exelon’s term loan. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
On August 4, 2022, Exelon entered into an agreement with certain underwriters in connection with an underwritten public offering (the “Offering”) of 11.3 million shares (the “Shares”) of its Common stock, no par value (“Common Stock”). The Shares were sold to the underwriters at a price per share of $ 43.32 . Exelon also granted the underwriters an option to purchase an additional 1.695 million shares of Common stock also at the price per share of $ 43.32 . On August 5, 2022, the underwriters exercised the option in full. The net proceeds from the Offering and the exercise of the underwriters’ option were $ 563 million before expenses paid by Exelon. Exelon used the proceeds, together with available cash balances, to repay $ 575 million in borrowings under a $ 1.15 billion term loan credit facility. See Note 16 — Debt and Credit Agreements for additional information on Exelon’s term loan. | text | no | perShareItemType | text: <entity> no </entity> <entity type> perShareItemType </entity type> <context> On August 4, 2022, Exelon entered into an agreement with certain underwriters in connection with an underwritten public offering (the “Offering”) of 11.3 million shares (the “Shares”) of its Common stock, no par value (“Common Stock”). The Shares were sold to the underwriters at a price per share of $ 43.32 . Exelon also granted the underwriters an option to purchase an additional 1.695 million shares of Common stock also at the price per share of $ 43.32 . On August 5, 2022, the underwriters exercised the option in full. The net proceeds from the Offering and the exercise of the underwriters’ option were $ 563 million before expenses paid by Exelon. Exelon used the proceeds, together with available cash balances, to repay $ 575 million in borrowings under a $ 1.15 billion term loan credit facility. See Note 16 — Debt and Credit Agreements for additional information on Exelon’s term loan. </context> | us-gaap:CommonStockParOrStatedValuePerShare |
On August 4, 2022, Exelon entered into an agreement with certain underwriters in connection with an underwritten public offering (the “Offering”) of 11.3 million shares (the “Shares”) of its Common stock, no par value (“Common Stock”). The Shares were sold to the underwriters at a price per share of $ 43.32 . Exelon also granted the underwriters an option to purchase an additional 1.695 million shares of Common stock also at the price per share of $ 43.32 . On August 5, 2022, the underwriters exercised the option in full. The net proceeds from the Offering and the exercise of the underwriters’ option were $ 563 million before expenses paid by Exelon. Exelon used the proceeds, together with available cash balances, to repay $ 575 million in borrowings under a $ 1.15 billion term loan credit facility. See Note 16 — Debt and Credit Agreements for additional information on Exelon’s term loan. | text | 43.32 | perShareItemType | text: <entity> 43.32 </entity> <entity type> perShareItemType </entity type> <context> On August 4, 2022, Exelon entered into an agreement with certain underwriters in connection with an underwritten public offering (the “Offering”) of 11.3 million shares (the “Shares”) of its Common stock, no par value (“Common Stock”). The Shares were sold to the underwriters at a price per share of $ 43.32 . Exelon also granted the underwriters an option to purchase an additional 1.695 million shares of Common stock also at the price per share of $ 43.32 . On August 5, 2022, the underwriters exercised the option in full. The net proceeds from the Offering and the exercise of the underwriters’ option were $ 563 million before expenses paid by Exelon. Exelon used the proceeds, together with available cash balances, to repay $ 575 million in borrowings under a $ 1.15 billion term loan credit facility. See Note 16 — Debt and Credit Agreements for additional information on Exelon’s term loan. </context> | us-gaap:SharePrice |
On August 4, 2022, Exelon entered into an agreement with certain underwriters in connection with an underwritten public offering (the “Offering”) of 11.3 million shares (the “Shares”) of its Common stock, no par value (“Common Stock”). The Shares were sold to the underwriters at a price per share of $ 43.32 . Exelon also granted the underwriters an option to purchase an additional 1.695 million shares of Common stock also at the price per share of $ 43.32 . On August 5, 2022, the underwriters exercised the option in full. The net proceeds from the Offering and the exercise of the underwriters’ option were $ 563 million before expenses paid by Exelon. Exelon used the proceeds, together with available cash balances, to repay $ 575 million in borrowings under a $ 1.15 billion term loan credit facility. See Note 16 — Debt and Credit Agreements for additional information on Exelon’s term loan. | text | 1.695 | sharesItemType | text: <entity> 1.695 </entity> <entity type> sharesItemType </entity type> <context> On August 4, 2022, Exelon entered into an agreement with certain underwriters in connection with an underwritten public offering (the “Offering”) of 11.3 million shares (the “Shares”) of its Common stock, no par value (“Common Stock”). The Shares were sold to the underwriters at a price per share of $ 43.32 . Exelon also granted the underwriters an option to purchase an additional 1.695 million shares of Common stock also at the price per share of $ 43.32 . On August 5, 2022, the underwriters exercised the option in full. The net proceeds from the Offering and the exercise of the underwriters’ option were $ 563 million before expenses paid by Exelon. Exelon used the proceeds, together with available cash balances, to repay $ 575 million in borrowings under a $ 1.15 billion term loan credit facility. See Note 16 — Debt and Credit Agreements for additional information on Exelon’s term loan. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
On August 4, 2022, Exelon entered into an agreement with certain underwriters in connection with an underwritten public offering (the “Offering”) of 11.3 million shares (the “Shares”) of its Common stock, no par value (“Common Stock”). The Shares were sold to the underwriters at a price per share of $ 43.32 . Exelon also granted the underwriters an option to purchase an additional 1.695 million shares of Common stock also at the price per share of $ 43.32 . On August 5, 2022, the underwriters exercised the option in full. The net proceeds from the Offering and the exercise of the underwriters’ option were $ 563 million before expenses paid by Exelon. Exelon used the proceeds, together with available cash balances, to repay $ 575 million in borrowings under a $ 1.15 billion term loan credit facility. See Note 16 — Debt and Credit Agreements for additional information on Exelon’s term loan. | text | 563 | monetaryItemType | text: <entity> 563 </entity> <entity type> monetaryItemType </entity type> <context> On August 4, 2022, Exelon entered into an agreement with certain underwriters in connection with an underwritten public offering (the “Offering”) of 11.3 million shares (the “Shares”) of its Common stock, no par value (“Common Stock”). The Shares were sold to the underwriters at a price per share of $ 43.32 . Exelon also granted the underwriters an option to purchase an additional 1.695 million shares of Common stock also at the price per share of $ 43.32 . On August 5, 2022, the underwriters exercised the option in full. The net proceeds from the Offering and the exercise of the underwriters’ option were $ 563 million before expenses paid by Exelon. Exelon used the proceeds, together with available cash balances, to repay $ 575 million in borrowings under a $ 1.15 billion term loan credit facility. See Note 16 — Debt and Credit Agreements for additional information on Exelon’s term loan. </context> | us-gaap:ProceedsFromIssuanceOrSaleOfEquity |
On August 4, 2022, Exelon entered into an agreement with certain underwriters in connection with an underwritten public offering (the “Offering”) of 11.3 million shares (the “Shares”) of its Common stock, no par value (“Common Stock”). The Shares were sold to the underwriters at a price per share of $ 43.32 . Exelon also granted the underwriters an option to purchase an additional 1.695 million shares of Common stock also at the price per share of $ 43.32 . On August 5, 2022, the underwriters exercised the option in full. The net proceeds from the Offering and the exercise of the underwriters’ option were $ 563 million before expenses paid by Exelon. Exelon used the proceeds, together with available cash balances, to repay $ 575 million in borrowings under a $ 1.15 billion term loan credit facility. See Note 16 — Debt and Credit Agreements for additional information on Exelon’s term loan. | text | 575 | monetaryItemType | text: <entity> 575 </entity> <entity type> monetaryItemType </entity type> <context> On August 4, 2022, Exelon entered into an agreement with certain underwriters in connection with an underwritten public offering (the “Offering”) of 11.3 million shares (the “Shares”) of its Common stock, no par value (“Common Stock”). The Shares were sold to the underwriters at a price per share of $ 43.32 . Exelon also granted the underwriters an option to purchase an additional 1.695 million shares of Common stock also at the price per share of $ 43.32 . On August 5, 2022, the underwriters exercised the option in full. The net proceeds from the Offering and the exercise of the underwriters’ option were $ 563 million before expenses paid by Exelon. Exelon used the proceeds, together with available cash balances, to repay $ 575 million in borrowings under a $ 1.15 billion term loan credit facility. See Note 16 — Debt and Credit Agreements for additional information on Exelon’s term loan. </context> | us-gaap:ProceedsFromRepaymentsOfDebt |
On August 4, 2022, Exelon entered into an agreement with certain underwriters in connection with an underwritten public offering (the “Offering”) of 11.3 million shares (the “Shares”) of its Common stock, no par value (“Common Stock”). The Shares were sold to the underwriters at a price per share of $ 43.32 . Exelon also granted the underwriters an option to purchase an additional 1.695 million shares of Common stock also at the price per share of $ 43.32 . On August 5, 2022, the underwriters exercised the option in full. The net proceeds from the Offering and the exercise of the underwriters’ option were $ 563 million before expenses paid by Exelon. Exelon used the proceeds, together with available cash balances, to repay $ 575 million in borrowings under a $ 1.15 billion term loan credit facility. See Note 16 — Debt and Credit Agreements for additional information on Exelon’s term loan. | text | 1.15 | monetaryItemType | text: <entity> 1.15 </entity> <entity type> monetaryItemType </entity type> <context> On August 4, 2022, Exelon entered into an agreement with certain underwriters in connection with an underwritten public offering (the “Offering”) of 11.3 million shares (the “Shares”) of its Common stock, no par value (“Common Stock”). The Shares were sold to the underwriters at a price per share of $ 43.32 . Exelon also granted the underwriters an option to purchase an additional 1.695 million shares of Common stock also at the price per share of $ 43.32 . On August 5, 2022, the underwriters exercised the option in full. The net proceeds from the Offering and the exercise of the underwriters’ option were $ 563 million before expenses paid by Exelon. Exelon used the proceeds, together with available cash balances, to repay $ 575 million in borrowings under a $ 1.15 billion term loan credit facility. See Note 16 — Debt and Credit Agreements for additional information on Exelon’s term loan. </context> | us-gaap:ShortTermBankLoansAndNotesPayable |
On August 4, 2022, Exelon executed an equity distribution agreement (“Equity Distribution Agreement”), with certain sales agents and forward sellers and certain forward purchasers, establishing an ATM equity distribution program under which it may offer and sell shares of its Common stock, having an aggregate gross sales price of up to $ 1.0 billion. Exelon has no obligation to offer or sell any shares of Common stock under the Equity Distribution Agreement and may, at any time, suspend or terminate offers and sales under the Equity Distribution Agreement. In November and December 2023, Exelon issued approximately 3.6 million shares of Common stock at an average gross price of $ 39.58 per share. The net proceeds from these issuances were $ 140 million, which were used for general corporate purposes. As of December 31, 2023, $ 858 million of Common stock remained available for sale pursuant to the ATM program. | text | 3.6 | sharesItemType | text: <entity> 3.6 </entity> <entity type> sharesItemType </entity type> <context> On August 4, 2022, Exelon executed an equity distribution agreement (“Equity Distribution Agreement”), with certain sales agents and forward sellers and certain forward purchasers, establishing an ATM equity distribution program under which it may offer and sell shares of its Common stock, having an aggregate gross sales price of up to $ 1.0 billion. Exelon has no obligation to offer or sell any shares of Common stock under the Equity Distribution Agreement and may, at any time, suspend or terminate offers and sales under the Equity Distribution Agreement. In November and December 2023, Exelon issued approximately 3.6 million shares of Common stock at an average gross price of $ 39.58 per share. The net proceeds from these issuances were $ 140 million, which were used for general corporate purposes. As of December 31, 2023, $ 858 million of Common stock remained available for sale pursuant to the ATM program. </context> | us-gaap:StockIssuedDuringPeriodSharesNewIssues |
On August 4, 2022, Exelon executed an equity distribution agreement (“Equity Distribution Agreement”), with certain sales agents and forward sellers and certain forward purchasers, establishing an ATM equity distribution program under which it may offer and sell shares of its Common stock, having an aggregate gross sales price of up to $ 1.0 billion. Exelon has no obligation to offer or sell any shares of Common stock under the Equity Distribution Agreement and may, at any time, suspend or terminate offers and sales under the Equity Distribution Agreement. In November and December 2023, Exelon issued approximately 3.6 million shares of Common stock at an average gross price of $ 39.58 per share. The net proceeds from these issuances were $ 140 million, which were used for general corporate purposes. As of December 31, 2023, $ 858 million of Common stock remained available for sale pursuant to the ATM program. | text | 39.58 | perShareItemType | text: <entity> 39.58 </entity> <entity type> perShareItemType </entity type> <context> On August 4, 2022, Exelon executed an equity distribution agreement (“Equity Distribution Agreement”), with certain sales agents and forward sellers and certain forward purchasers, establishing an ATM equity distribution program under which it may offer and sell shares of its Common stock, having an aggregate gross sales price of up to $ 1.0 billion. Exelon has no obligation to offer or sell any shares of Common stock under the Equity Distribution Agreement and may, at any time, suspend or terminate offers and sales under the Equity Distribution Agreement. In November and December 2023, Exelon issued approximately 3.6 million shares of Common stock at an average gross price of $ 39.58 per share. The net proceeds from these issuances were $ 140 million, which were used for general corporate purposes. As of December 31, 2023, $ 858 million of Common stock remained available for sale pursuant to the ATM program. </context> | us-gaap:SharePrice |
On August 4, 2022, Exelon executed an equity distribution agreement (“Equity Distribution Agreement”), with certain sales agents and forward sellers and certain forward purchasers, establishing an ATM equity distribution program under which it may offer and sell shares of its Common stock, having an aggregate gross sales price of up to $ 1.0 billion. Exelon has no obligation to offer or sell any shares of Common stock under the Equity Distribution Agreement and may, at any time, suspend or terminate offers and sales under the Equity Distribution Agreement. In November and December 2023, Exelon issued approximately 3.6 million shares of Common stock at an average gross price of $ 39.58 per share. The net proceeds from these issuances were $ 140 million, which were used for general corporate purposes. As of December 31, 2023, $ 858 million of Common stock remained available for sale pursuant to the ATM program. | text | 140 | monetaryItemType | text: <entity> 140 </entity> <entity type> monetaryItemType </entity type> <context> On August 4, 2022, Exelon executed an equity distribution agreement (“Equity Distribution Agreement”), with certain sales agents and forward sellers and certain forward purchasers, establishing an ATM equity distribution program under which it may offer and sell shares of its Common stock, having an aggregate gross sales price of up to $ 1.0 billion. Exelon has no obligation to offer or sell any shares of Common stock under the Equity Distribution Agreement and may, at any time, suspend or terminate offers and sales under the Equity Distribution Agreement. In November and December 2023, Exelon issued approximately 3.6 million shares of Common stock at an average gross price of $ 39.58 per share. The net proceeds from these issuances were $ 140 million, which were used for general corporate purposes. As of December 31, 2023, $ 858 million of Common stock remained available for sale pursuant to the ATM program. </context> | us-gaap:ProceedsFromIssuanceOfCommonStock |
There currently is no Exelon Board of Director authority to repurchase shares. Any previous shares repurchased are held as treasury shares, at cost, unless cancelled or reissued at the discretion of Exelon’s management. | text | no | sharesItemType | text: <entity> no </entity> <entity type> sharesItemType </entity type> <context> There currently is no Exelon Board of Director authority to repurchase shares. Any previous shares repurchased are held as treasury shares, at cost, unless cancelled or reissued at the discretion of Exelon’s management. </context> | us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased |
Exelon grants stock-based awards through its LTIP, which primarily includes performance share awards, restricted stock units, and stock options. At December 31, 2023, there were approximately 33 million shares authorized for issuance under the LTIP. For the years ended December 31, 2023, 2022, and 2021, exercised and distributed stock-based awards were primarily issued from authorized but unissued Common stock shares. | text | 33 | sharesItemType | text: <entity> 33 </entity> <entity type> sharesItemType </entity type> <context> Exelon grants stock-based awards through its LTIP, which primarily includes performance share awards, restricted stock units, and stock options. At December 31, 2023, there were approximately 33 million shares authorized for issuance under the LTIP. For the years ended December 31, 2023, 2022, and 2021, exercised and distributed stock-based awards were primarily issued from authorized but unissued Common stock shares. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
As of December 31, 2023, $ 11 million of total unrecognized compensation costs related to nonvested performance shares are expected to be recognized over the remaining weighted-average period of 1.8 years. | text | 11 | monetaryItemType | text: <entity> 11 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, $ 11 million of total unrecognized compensation costs related to nonvested performance shares are expected to be recognized over the remaining weighted-average period of 1.8 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions |
There were no stock options granted during the year ended December 31, 2023. All stock options were vested and exercised as of December 31, 2022. | text | no | sharesItemType | text: <entity> no </entity> <entity type> sharesItemType </entity type> <context> There were no stock options granted during the year ended December 31, 2023. All stock options were vested and exercised as of December 31, 2022. </context> | us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised |
Exelon Corporate meets its short-term liquidity requirements primarily through the issuance of commercial paper. Exelon Corporate had $ 527 million in outstanding commercial paper borrowings as of December 31, 2023 and $ 449 million outstanding commercial paper as of December 31, 2022. | text | 527 | monetaryItemType | text: <entity> 527 </entity> <entity type> monetaryItemType </entity type> <context> Exelon Corporate meets its short-term liquidity requirements primarily through the issuance of commercial paper. Exelon Corporate had $ 527 million in outstanding commercial paper borrowings as of December 31, 2023 and $ 449 million outstanding commercial paper as of December 31, 2022. </context> | us-gaap:CommercialPaper |
Exelon Corporate meets its short-term liquidity requirements primarily through the issuance of commercial paper. Exelon Corporate had $ 527 million in outstanding commercial paper borrowings as of December 31, 2023 and $ 449 million outstanding commercial paper as of December 31, 2022. | text | 449 | monetaryItemType | text: <entity> 449 </entity> <entity type> monetaryItemType </entity type> <context> Exelon Corporate meets its short-term liquidity requirements primarily through the issuance of commercial paper. Exelon Corporate had $ 527 million in outstanding commercial paper borrowings as of December 31, 2023 and $ 449 million outstanding commercial paper as of December 31, 2022. </context> | us-gaap:CommercialPaper |
As of December 31, 2023, Exelon Corporation had a $ 900 million aggregate bank commitment under its existing syndicated revolving facility in which $ 370 million was available to support additional commercial paper as of December 31, 2023. See Note 16 — Debt and Credit Agreements of the Combined Notes to Consolidated Financial Statements for additional information regarding Exelon Corporate’s credit agreement. | text | 900 | monetaryItemType | text: <entity> 900 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, Exelon Corporation had a $ 900 million aggregate bank commitment under its existing syndicated revolving facility in which $ 370 million was available to support additional commercial paper as of December 31, 2023. See Note 16 — Debt and Credit Agreements of the Combined Notes to Consolidated Financial Statements for additional information regarding Exelon Corporate’s credit agreement. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
As of December 31, 2023, Exelon Corporation had a $ 900 million aggregate bank commitment under its existing syndicated revolving facility in which $ 370 million was available to support additional commercial paper as of December 31, 2023. See Note 16 — Debt and Credit Agreements of the Combined Notes to Consolidated Financial Statements for additional information regarding Exelon Corporate’s credit agreement. | text | 370 | monetaryItemType | text: <entity> 370 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, Exelon Corporation had a $ 900 million aggregate bank commitment under its existing syndicated revolving facility in which $ 370 million was available to support additional commercial paper as of December 31, 2023. See Note 16 — Debt and Credit Agreements of the Combined Notes to Consolidated Financial Statements for additional information regarding Exelon Corporate’s credit agreement. </context> | us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity |
On February 1, 2022, Exelon Corporate entered into a new 5-year revolving credit facility with an aggregate bank commitment of $ 900 million at a variable interest rate of SOFR plus 1.275 % which replaced its existing $ 600 million syndicated revolving credit facility. | text | 900 | monetaryItemType | text: <entity> 900 </entity> <entity type> monetaryItemType </entity type> <context> On February 1, 2022, Exelon Corporate entered into a new 5-year revolving credit facility with an aggregate bank commitment of $ 900 million at a variable interest rate of SOFR plus 1.275 % which replaced its existing $ 600 million syndicated revolving credit facility. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
On February 1, 2022, Exelon Corporate entered into a new 5-year revolving credit facility with an aggregate bank commitment of $ 900 million at a variable interest rate of SOFR plus 1.275 % which replaced its existing $ 600 million syndicated revolving credit facility. | text | 1.275 | percentItemType | text: <entity> 1.275 </entity> <entity type> percentItemType </entity type> <context> On February 1, 2022, Exelon Corporate entered into a new 5-year revolving credit facility with an aggregate bank commitment of $ 900 million at a variable interest rate of SOFR plus 1.275 % which replaced its existing $ 600 million syndicated revolving credit facility. </context> | us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd |
On February 1, 2022, Exelon Corporate entered into a new 5-year revolving credit facility with an aggregate bank commitment of $ 900 million at a variable interest rate of SOFR plus 1.275 % which replaced its existing $ 600 million syndicated revolving credit facility. | text | 600 | monetaryItemType | text: <entity> 600 </entity> <entity type> monetaryItemType </entity type> <context> On February 1, 2022, Exelon Corporate entered into a new 5-year revolving credit facility with an aggregate bank commitment of $ 900 million at a variable interest rate of SOFR plus 1.275 % which replaced its existing $ 600 million syndicated revolving credit facility. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
Exelon Corporate had no outstanding amounts on the revolving credit facilities as of December 31, 2023. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> Exelon Corporate had no outstanding amounts on the revolving credit facilities as of December 31, 2023. </context> | us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod |
Senior unsecured notes included mirror debt that was held on Exelon Corporation's Balance Sheet in 2021. In connection with the separation, on January 31, 2022, Exelon Corporate received cash from Generation of $ 258 million to settle the intercompany loan. See Note 16 — Debt and Credit Agreements for additional information on the merger debt. | text | 258 | monetaryItemType | text: <entity> 258 </entity> <entity type> monetaryItemType </entity type> <context> Senior unsecured notes included mirror debt that was held on Exelon Corporation's Balance Sheet in 2021. In connection with the separation, on January 31, 2022, Exelon Corporate received cash from Generation of $ 258 million to settle the intercompany loan. See Note 16 — Debt and Credit Agreements for additional information on the merger debt. </context> | us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable |
In connection with the separation, Exelon Corporate entered into three 18-month term loan agreements. On January 21, 2022, two of the loan agreements were issued for $ 300 million each with an expiration date of July 21, 2023. On January 24, 2022, the third loan agreement was issued for $ 250 million with an expiration date of July 24, 2023. Pursuant to the loan agreement, loans made thereunder bear interest at a variable rate equal to SOFR plus 0.65 %. | text | 300 | monetaryItemType | text: <entity> 300 </entity> <entity type> monetaryItemType </entity type> <context> In connection with the separation, Exelon Corporate entered into three 18-month term loan agreements. On January 21, 2022, two of the loan agreements were issued for $ 300 million each with an expiration date of July 21, 2023. On January 24, 2022, the third loan agreement was issued for $ 250 million with an expiration date of July 24, 2023. Pursuant to the loan agreement, loans made thereunder bear interest at a variable rate equal to SOFR plus 0.65 %. </context> | us-gaap:DebtInstrumentCarryingAmount |
In connection with the separation, Exelon Corporate entered into three 18-month term loan agreements. On January 21, 2022, two of the loan agreements were issued for $ 300 million each with an expiration date of July 21, 2023. On January 24, 2022, the third loan agreement was issued for $ 250 million with an expiration date of July 24, 2023. Pursuant to the loan agreement, loans made thereunder bear interest at a variable rate equal to SOFR plus 0.65 %. | text | 250 | monetaryItemType | text: <entity> 250 </entity> <entity type> monetaryItemType </entity type> <context> In connection with the separation, Exelon Corporate entered into three 18-month term loan agreements. On January 21, 2022, two of the loan agreements were issued for $ 300 million each with an expiration date of July 21, 2023. On January 24, 2022, the third loan agreement was issued for $ 250 million with an expiration date of July 24, 2023. Pursuant to the loan agreement, loans made thereunder bear interest at a variable rate equal to SOFR plus 0.65 %. </context> | us-gaap:DebtInstrumentCarryingAmount |
Excludes the noncurrent Allowance for credit losses related to PECO’s installment plan receivables of $ 6 million, $ 7 million, and $ 14 million for the years ended December 31, 2023, 2022, and 2021, respectively. | text | 6 | monetaryItemType | text: <entity> 6 </entity> <entity type> monetaryItemType </entity type> <context> Excludes the noncurrent Allowance for credit losses related to PECO’s installment plan receivables of $ 6 million, $ 7 million, and $ 14 million for the years ended December 31, 2023, 2022, and 2021, respectively. </context> | us-gaap:ValuationAllowancesAndReservesBalance |
Excludes the noncurrent Allowance for credit losses related to PECO’s installment plan receivables of $ 6 million, $ 7 million, and $ 14 million for the years ended December 31, 2023, 2022, and 2021, respectively. | text | 7 | monetaryItemType | text: <entity> 7 </entity> <entity type> monetaryItemType </entity type> <context> Excludes the noncurrent Allowance for credit losses related to PECO’s installment plan receivables of $ 6 million, $ 7 million, and $ 14 million for the years ended December 31, 2023, 2022, and 2021, respectively. </context> | us-gaap:ValuationAllowancesAndReservesBalance |
Excludes the noncurrent Allowance for credit losses related to PECO’s installment plan receivables of $ 6 million, $ 7 million, and $ 14 million for the years ended December 31, 2023, 2022, and 2021, respectively. | text | 14 | monetaryItemType | text: <entity> 14 </entity> <entity type> monetaryItemType </entity type> <context> Excludes the noncurrent Allowance for credit losses related to PECO’s installment plan receivables of $ 6 million, $ 7 million, and $ 14 million for the years ended December 31, 2023, 2022, and 2021, respectively. </context> | us-gaap:ValuationAllowancesAndReservesBalance |
We have two lines of business: | text | two | integerItemType | text: <entity> two </entity> <entity type> integerItemType </entity type> <context> We have two lines of business: </context> | us-gaap:NumberOfReportableSegments |
Includes $ 14 million of loans classified as held-for-sale that were measured at fair value in level 2 as of December 31, 2024. | text | 14 | monetaryItemType | text: <entity> 14 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 14 million of loans classified as held-for-sale that were measured at fair value in level 2 as of December 31, 2024. </context> | us-gaap:LoansHeldForSaleFairValueDisclosure |
As of December 31, 2024 and 2023, the total fair value included $ 4.36 billion and $ 5.54 billion, respectively, of agency CMBS and $ 6.20 billion and $ 5.21 billion, respectively, of agency MBS. | text | 4.36 | monetaryItemType | text: <entity> 4.36 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the total fair value included $ 4.36 billion and $ 5.54 billion, respectively, of agency CMBS and $ 6.20 billion and $ 5.21 billion, respectively, of agency MBS. </context> | us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss |
As of December 31, 2024 and 2023, the total fair value included $ 4.36 billion and $ 5.54 billion, respectively, of agency CMBS and $ 6.20 billion and $ 5.21 billion, respectively, of agency MBS. | text | 5.54 | monetaryItemType | text: <entity> 5.54 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the total fair value included $ 4.36 billion and $ 5.54 billion, respectively, of agency CMBS and $ 6.20 billion and $ 5.21 billion, respectively, of agency MBS. </context> | us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss |
As of December 31, 2024 and 2023, the total fair value included $ 4.36 billion and $ 5.54 billion, respectively, of agency CMBS and $ 6.20 billion and $ 5.21 billion, respectively, of agency MBS. | text | 6.20 | monetaryItemType | text: <entity> 6.20 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the total fair value included $ 4.36 billion and $ 5.54 billion, respectively, of agency CMBS and $ 6.20 billion and $ 5.21 billion, respectively, of agency MBS. </context> | us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss |
As of December 31, 2024 and 2023, the total fair value included $ 4.36 billion and $ 5.54 billion, respectively, of agency CMBS and $ 6.20 billion and $ 5.21 billion, respectively, of agency MBS. | text | 5.21 | monetaryItemType | text: <entity> 5.21 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the total fair value included $ 4.36 billion and $ 5.54 billion, respectively, of agency CMBS and $ 6.20 billion and $ 5.21 billion, respectively, of agency MBS. </context> | us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss |
As of December 31, 2024 and 2023, the fair value includes non-U.S. collateralized loan obligations of $ 0.70 billion and $ 1.02 billion, respectively. | text | 0.70 | monetaryItemType | text: <entity> 0.70 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the fair value includes non-U.S. collateralized loan obligations of $ 0.70 billion and $ 1.02 billion, respectively. </context> | us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss |
As of December 31, 2024 and 2023, the fair value includes non-U.S. collateralized loan obligations of $ 0.70 billion and $ 1.02 billion, respectively. | text | 1.02 | monetaryItemType | text: <entity> 1.02 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the fair value includes non-U.S. collateralized loan obligations of $ 0.70 billion and $ 1.02 billion, respectively. </context> | us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss |
As of December 31, 2024 and 2023, the fair value includes non-U.S. corporate bonds of $ 2.54 billion and $ 2.36 billion, respectively. | text | 2.54 | monetaryItemType | text: <entity> 2.54 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the fair value includes non-U.S. corporate bonds of $ 2.54 billion and $ 2.36 billion, respectively. </context> | us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss |
As of December 31, 2024 and 2023, the fair value includes non-U.S. corporate bonds of $ 2.54 billion and $ 2.36 billion, respectively. | text | 2.36 | monetaryItemType | text: <entity> 2.36 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the fair value includes non-U.S. corporate bonds of $ 2.54 billion and $ 2.36 billion, respectively. </context> | us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss |
As of December 31, 2024 and 2023, the fair value of U.S. corporate bonds was $ 0.05 billion and $ 0.31 billion, respectively. | text | 0.05 | monetaryItemType | text: <entity> 0.05 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the fair value of U.S. corporate bonds was $ 0.05 billion and $ 0.31 billion, respectively. </context> | us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss |
As of December 31, 2024 and 2023, the fair value of U.S. corporate bonds was $ 0.05 billion and $ 0.31 billion, respectively. | text | 0.31 | monetaryItemType | text: <entity> 0.31 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the fair value of U.S. corporate bonds was $ 0.05 billion and $ 0.31 billion, respectively. </context> | us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss |
As of December 31, 2024 and 2023, the total amortized cost included $ 5.18 billion and $ 5.23 billion of agency CMBS, respectively. | text | 5.18 | monetaryItemType | text: <entity> 5.18 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the total amortized cost included $ 5.18 billion and $ 5.23 billion of agency CMBS, respectively. </context> | us-gaap:DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss |
As of December 31, 2024 and 2023, the total amortized cost included $ 5.18 billion and $ 5.23 billion of agency CMBS, respectively. | text | 5.23 | monetaryItemType | text: <entity> 5.23 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the total amortized cost included $ 5.18 billion and $ 5.23 billion of agency CMBS, respectively. </context> | us-gaap:DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss |
As of December 31, 2024, we had no allowance for credit losses on HTM investment securities. As of December 31, 2023, we had $ 1 million allowance for credit losses on HTM investment securities. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, we had no allowance for credit losses on HTM investment securities. As of December 31, 2023, we had $ 1 million allowance for credit losses on HTM investment securities. </context> | us-gaap:DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest |
As of December 31, 2024, we had no allowance for credit losses on HTM investment securities. As of December 31, 2023, we had $ 1 million allowance for credit losses on HTM investment securities. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, we had no allowance for credit losses on HTM investment securities. As of December 31, 2023, we had $ 1 million allowance for credit losses on HTM investment securities. </context> | us-gaap:DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest |
Aggregate investment securities with carrying values of approximately $ 86.70 billion and $ 71.30 billion as of December 31, 2024 and 2023, respectively, were designated as pledged for public and trust deposits, short-term borrowings and for other purposes as provided by law. | text | 86.70 | monetaryItemType | text: <entity> 86.70 </entity> <entity type> monetaryItemType </entity type> <context> Aggregate investment securities with carrying values of approximately $ 86.70 billion and $ 71.30 billion as of December 31, 2024 and 2023, respectively, were designated as pledged for public and trust deposits, short-term borrowings and for other purposes as provided by law. </context> | us-gaap:DebtSecurities |
Aggregate investment securities with carrying values of approximately $ 86.70 billion and $ 71.30 billion as of December 31, 2024 and 2023, respectively, were designated as pledged for public and trust deposits, short-term borrowings and for other purposes as provided by law. | text | 71.30 | monetaryItemType | text: <entity> 71.30 </entity> <entity type> monetaryItemType </entity type> <context> Aggregate investment securities with carrying values of approximately $ 86.70 billion and $ 71.30 billion as of December 31, 2024 and 2023, respectively, were designated as pledged for public and trust deposits, short-term borrowings and for other purposes as provided by law. </context> | us-gaap:DebtSecurities |
In 2024, 2023 and 2022, proceeds from sales of AFS securities were approximately $ 10.97 billion, $ 4.92 billion and $ 4.59 billion, respectively, resulting in a pre-tax loss of approximately $ 79 million, $ 294 million and $ 2 million in 2024, 2023 and 2022, respectively. The pre-tax loss in 2024 was primarily driven by sales of U.S. Treasury, non-U.S. agency, supranational and mortgage-backed securities as part of an investment portfolio repositioning in the third quarter of 2024. | text | 79 | monetaryItemType | text: <entity> 79 </entity> <entity type> monetaryItemType </entity type> <context> In 2024, 2023 and 2022, proceeds from sales of AFS securities were approximately $ 10.97 billion, $ 4.92 billion and $ 4.59 billion, respectively, resulting in a pre-tax loss of approximately $ 79 million, $ 294 million and $ 2 million in 2024, 2023 and 2022, respectively. The pre-tax loss in 2024 was primarily driven by sales of U.S. Treasury, non-U.S. agency, supranational and mortgage-backed securities as part of an investment portfolio repositioning in the third quarter of 2024. </context> | us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss |
In 2024, 2023 and 2022, proceeds from sales of AFS securities were approximately $ 10.97 billion, $ 4.92 billion and $ 4.59 billion, respectively, resulting in a pre-tax loss of approximately $ 79 million, $ 294 million and $ 2 million in 2024, 2023 and 2022, respectively. The pre-tax loss in 2024 was primarily driven by sales of U.S. Treasury, non-U.S. agency, supranational and mortgage-backed securities as part of an investment portfolio repositioning in the third quarter of 2024. | text | 294 | monetaryItemType | text: <entity> 294 </entity> <entity type> monetaryItemType </entity type> <context> In 2024, 2023 and 2022, proceeds from sales of AFS securities were approximately $ 10.97 billion, $ 4.92 billion and $ 4.59 billion, respectively, resulting in a pre-tax loss of approximately $ 79 million, $ 294 million and $ 2 million in 2024, 2023 and 2022, respectively. The pre-tax loss in 2024 was primarily driven by sales of U.S. Treasury, non-U.S. agency, supranational and mortgage-backed securities as part of an investment portfolio repositioning in the third quarter of 2024. </context> | us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss |
In 2024, 2023 and 2022, proceeds from sales of AFS securities were approximately $ 10.97 billion, $ 4.92 billion and $ 4.59 billion, respectively, resulting in a pre-tax loss of approximately $ 79 million, $ 294 million and $ 2 million in 2024, 2023 and 2022, respectively. The pre-tax loss in 2024 was primarily driven by sales of U.S. Treasury, non-U.S. agency, supranational and mortgage-backed securities as part of an investment portfolio repositioning in the third quarter of 2024. | text | 2 | monetaryItemType | text: <entity> 2 </entity> <entity type> monetaryItemType </entity type> <context> In 2024, 2023 and 2022, proceeds from sales of AFS securities were approximately $ 10.97 billion, $ 4.92 billion and $ 4.59 billion, respectively, resulting in a pre-tax loss of approximately $ 79 million, $ 294 million and $ 2 million in 2024, 2023 and 2022, respectively. The pre-tax loss in 2024 was primarily driven by sales of U.S. Treasury, non-U.S. agency, supranational and mortgage-backed securities as part of an investment portfolio repositioning in the third quarter of 2024. </context> | us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss |
After a review of the investment portfolio, taking into consideration then-current economic conditions, adverse situations that might affect our ability to fully collect principal and interest, the timing of future payments, the credit quality and performance of the collateral underlying MBS and ABS and other relevant factors, management considered the aggregate decline in fair value of the investment securities portfolio and the resulting gross pre-tax unrealized losses of $ 6.12 billion and $ 6.19 billion related to | text | 6.12 | monetaryItemType | text: <entity> 6.12 </entity> <entity type> monetaryItemType </entity type> <context> After a review of the investment portfolio, taking into consideration then-current economic conditions, adverse situations that might affect our ability to fully collect principal and interest, the timing of future payments, the credit quality and performance of the collateral underlying MBS and ABS and other relevant factors, management considered the aggregate decline in fair value of the investment securities portfolio and the resulting gross pre-tax unrealized losses of $ 6.12 billion and $ 6.19 billion related to </context> | us-gaap:MarketableSecuritiesUnrealizedGainLoss |
After a review of the investment portfolio, taking into consideration then-current economic conditions, adverse situations that might affect our ability to fully collect principal and interest, the timing of future payments, the credit quality and performance of the collateral underlying MBS and ABS and other relevant factors, management considered the aggregate decline in fair value of the investment securities portfolio and the resulting gross pre-tax unrealized losses of $ 6.12 billion and $ 6.19 billion related to | text | 6.19 | monetaryItemType | text: <entity> 6.19 </entity> <entity type> monetaryItemType </entity type> <context> After a review of the investment portfolio, taking into consideration then-current economic conditions, adverse situations that might affect our ability to fully collect principal and interest, the timing of future payments, the credit quality and performance of the collateral underlying MBS and ABS and other relevant factors, management considered the aggregate decline in fair value of the investment securities portfolio and the resulting gross pre-tax unrealized losses of $ 6.12 billion and $ 6.19 billion related to </context> | us-gaap:MarketableSecuritiesUnrealizedGainLoss |
Fund finance loans include primarily $ 11.54 billion private equity capital call finance loans, $ 8.09 billion loans to real money funds and $ 1.44 billion loans to business development companies as of December 31, 2024, compared to $ 9.69 billion private equity capital call finance loans, $ 6.63 billion loans to real money funds and $ 1.05 billion loans to business development companies as of December 31, 2023. | text | 11.54 | monetaryItemType | text: <entity> 11.54 </entity> <entity type> monetaryItemType </entity type> <context> Fund finance loans include primarily $ 11.54 billion private equity capital call finance loans, $ 8.09 billion loans to real money funds and $ 1.44 billion loans to business development companies as of December 31, 2024, compared to $ 9.69 billion private equity capital call finance loans, $ 6.63 billion loans to real money funds and $ 1.05 billion loans to business development companies as of December 31, 2023. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
Fund finance loans include primarily $ 11.54 billion private equity capital call finance loans, $ 8.09 billion loans to real money funds and $ 1.44 billion loans to business development companies as of December 31, 2024, compared to $ 9.69 billion private equity capital call finance loans, $ 6.63 billion loans to real money funds and $ 1.05 billion loans to business development companies as of December 31, 2023. | text | 8.09 | monetaryItemType | text: <entity> 8.09 </entity> <entity type> monetaryItemType </entity type> <context> Fund finance loans include primarily $ 11.54 billion private equity capital call finance loans, $ 8.09 billion loans to real money funds and $ 1.44 billion loans to business development companies as of December 31, 2024, compared to $ 9.69 billion private equity capital call finance loans, $ 6.63 billion loans to real money funds and $ 1.05 billion loans to business development companies as of December 31, 2023. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
Fund finance loans include primarily $ 11.54 billion private equity capital call finance loans, $ 8.09 billion loans to real money funds and $ 1.44 billion loans to business development companies as of December 31, 2024, compared to $ 9.69 billion private equity capital call finance loans, $ 6.63 billion loans to real money funds and $ 1.05 billion loans to business development companies as of December 31, 2023. | text | 1.44 | monetaryItemType | text: <entity> 1.44 </entity> <entity type> monetaryItemType </entity type> <context> Fund finance loans include primarily $ 11.54 billion private equity capital call finance loans, $ 8.09 billion loans to real money funds and $ 1.44 billion loans to business development companies as of December 31, 2024, compared to $ 9.69 billion private equity capital call finance loans, $ 6.63 billion loans to real money funds and $ 1.05 billion loans to business development companies as of December 31, 2023. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
Fund finance loans include primarily $ 11.54 billion private equity capital call finance loans, $ 8.09 billion loans to real money funds and $ 1.44 billion loans to business development companies as of December 31, 2024, compared to $ 9.69 billion private equity capital call finance loans, $ 6.63 billion loans to real money funds and $ 1.05 billion loans to business development companies as of December 31, 2023. | text | 9.69 | monetaryItemType | text: <entity> 9.69 </entity> <entity type> monetaryItemType </entity type> <context> Fund finance loans include primarily $ 11.54 billion private equity capital call finance loans, $ 8.09 billion loans to real money funds and $ 1.44 billion loans to business development companies as of December 31, 2024, compared to $ 9.69 billion private equity capital call finance loans, $ 6.63 billion loans to real money funds and $ 1.05 billion loans to business development companies as of December 31, 2023. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
Fund finance loans include primarily $ 11.54 billion private equity capital call finance loans, $ 8.09 billion loans to real money funds and $ 1.44 billion loans to business development companies as of December 31, 2024, compared to $ 9.69 billion private equity capital call finance loans, $ 6.63 billion loans to real money funds and $ 1.05 billion loans to business development companies as of December 31, 2023. | text | 6.63 | monetaryItemType | text: <entity> 6.63 </entity> <entity type> monetaryItemType </entity type> <context> Fund finance loans include primarily $ 11.54 billion private equity capital call finance loans, $ 8.09 billion loans to real money funds and $ 1.44 billion loans to business development companies as of December 31, 2024, compared to $ 9.69 billion private equity capital call finance loans, $ 6.63 billion loans to real money funds and $ 1.05 billion loans to business development companies as of December 31, 2023. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
Fund finance loans include primarily $ 11.54 billion private equity capital call finance loans, $ 8.09 billion loans to real money funds and $ 1.44 billion loans to business development companies as of December 31, 2024, compared to $ 9.69 billion private equity capital call finance loans, $ 6.63 billion loans to real money funds and $ 1.05 billion loans to business development companies as of December 31, 2023. | text | 1.05 | monetaryItemType | text: <entity> 1.05 </entity> <entity type> monetaryItemType </entity type> <context> Fund finance loans include primarily $ 11.54 billion private equity capital call finance loans, $ 8.09 billion loans to real money funds and $ 1.44 billion loans to business development companies as of December 31, 2024, compared to $ 9.69 billion private equity capital call finance loans, $ 6.63 billion loans to real money funds and $ 1.05 billion loans to business development companies as of December 31, 2023. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
Includes $ 3.01 billion securities finance loans and $ 214 million loans to municipalities as of December 31, 2024 and $ 2.23 billion securities finance loans, $ 276 million loans to municipalities and $ 5 million other loans as of December 31, 2023. | text | 3.01 | monetaryItemType | text: <entity> 3.01 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 3.01 billion securities finance loans and $ 214 million loans to municipalities as of December 31, 2024 and $ 2.23 billion securities finance loans, $ 276 million loans to municipalities and $ 5 million other loans as of December 31, 2023. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
Includes $ 3.01 billion securities finance loans and $ 214 million loans to municipalities as of December 31, 2024 and $ 2.23 billion securities finance loans, $ 276 million loans to municipalities and $ 5 million other loans as of December 31, 2023. | text | 214 | monetaryItemType | text: <entity> 214 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 3.01 billion securities finance loans and $ 214 million loans to municipalities as of December 31, 2024 and $ 2.23 billion securities finance loans, $ 276 million loans to municipalities and $ 5 million other loans as of December 31, 2023. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
Includes $ 3.01 billion securities finance loans and $ 214 million loans to municipalities as of December 31, 2024 and $ 2.23 billion securities finance loans, $ 276 million loans to municipalities and $ 5 million other loans as of December 31, 2023. | text | 2.23 | monetaryItemType | text: <entity> 2.23 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 3.01 billion securities finance loans and $ 214 million loans to municipalities as of December 31, 2024 and $ 2.23 billion securities finance loans, $ 276 million loans to municipalities and $ 5 million other loans as of December 31, 2023. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
Includes $ 3.01 billion securities finance loans and $ 214 million loans to municipalities as of December 31, 2024 and $ 2.23 billion securities finance loans, $ 276 million loans to municipalities and $ 5 million other loans as of December 31, 2023. | text | 276 | monetaryItemType | text: <entity> 276 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 3.01 billion securities finance loans and $ 214 million loans to municipalities as of December 31, 2024 and $ 2.23 billion securities finance loans, $ 276 million loans to municipalities and $ 5 million other loans as of December 31, 2023. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
Includes $ 3.01 billion securities finance loans and $ 214 million loans to municipalities as of December 31, 2024 and $ 2.23 billion securities finance loans, $ 276 million loans to municipalities and $ 5 million other loans as of December 31, 2023. | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 3.01 billion securities finance loans and $ 214 million loans to municipalities as of December 31, 2024 and $ 2.23 billion securities finance loans, $ 276 million loans to municipalities and $ 5 million other loans as of December 31, 2023. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
As of December 31, 2024, excluding overdrafts, floating rate loans totaled $ 38.46 billion and fixed rate loans totaled $ 2.76 billion. We have entered into interest rate swap agreements to hedge the forecasted cash flows associated with EURIBOR indexed floating-rate loans. See Note 10 for additional details. | text | 38.46 | monetaryItemType | text: <entity> 38.46 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, excluding overdrafts, floating rate loans totaled $ 38.46 billion and fixed rate loans totaled $ 2.76 billion. We have entered into interest rate swap agreements to hedge the forecasted cash flows associated with EURIBOR indexed floating-rate loans. See Note 10 for additional details. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
As of December 31, 2024, excluding overdrafts, floating rate loans totaled $ 38.46 billion and fixed rate loans totaled $ 2.76 billion. We have entered into interest rate swap agreements to hedge the forecasted cash flows associated with EURIBOR indexed floating-rate loans. See Note 10 for additional details. | text | 2.76 | monetaryItemType | text: <entity> 2.76 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, excluding overdrafts, floating rate loans totaled $ 38.46 billion and fixed rate loans totaled $ 2.76 billion. We have entered into interest rate swap agreements to hedge the forecasted cash flows associated with EURIBOR indexed floating-rate loans. See Note 10 for additional details. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
Certain loans are pledged as collateral for access to the Federal Reserve’s discount window. As of December 31, 2024 and 2023, the loans pledged as collateral totaled $ 13.90 billion and $ 13.00 billion, respectively. | text | 13.90 | monetaryItemType | text: <entity> 13.90 </entity> <entity type> monetaryItemType </entity type> <context> Certain loans are pledged as collateral for access to the Federal Reserve’s discount window. As of December 31, 2024 and 2023, the loans pledged as collateral totaled $ 13.90 billion and $ 13.00 billion, respectively. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss |
Certain loans are pledged as collateral for access to the Federal Reserve’s discount window. As of December 31, 2024 and 2023, the loans pledged as collateral totaled $ 13.90 billion and $ 13.00 billion, respectively. | text | 13.00 | monetaryItemType | text: <entity> 13.00 </entity> <entity type> monetaryItemType </entity type> <context> Certain loans are pledged as collateral for access to the Federal Reserve’s discount window. As of December 31, 2024 and 2023, the loans pledged as collateral totaled $ 13.90 billion and $ 13.00 billion, respectively. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss |
We generally place loans on non-accrual status once principal or interest payments are 90 days contractually past due, or earlier if management determines that full collection is not probable. Loans 90 days past due, but considered both well-secured and in the process of collection, may be excluded from non-accrual status. When we place a loan on non-accrual status, the accrual of interest is discontinued and previously recorded but unpaid interest is reversed and generally charged against interest income. For loans on non-accrual status, income is recognized on a cash basis after recovery of principal, if and when interest payments are received. Loans may be removed from non-accrual status when repayment is reasonably assured and performance under the terms of the loan has been demonstrated. As of December 31, 2024, we had two loans totaling $ 191 million on non-accrual status, of which one loan totaling $ 101 million was more than 90 days contractually past due. As of December 31, 2023, we had three loans totaling $ 70 million on non-accrual status. | text | 191 | monetaryItemType | text: <entity> 191 </entity> <entity type> monetaryItemType </entity type> <context> We generally place loans on non-accrual status once principal or interest payments are 90 days contractually past due, or earlier if management determines that full collection is not probable. Loans 90 days past due, but considered both well-secured and in the process of collection, may be excluded from non-accrual status. When we place a loan on non-accrual status, the accrual of interest is discontinued and previously recorded but unpaid interest is reversed and generally charged against interest income. For loans on non-accrual status, income is recognized on a cash basis after recovery of principal, if and when interest payments are received. Loans may be removed from non-accrual status when repayment is reasonably assured and performance under the terms of the loan has been demonstrated. As of December 31, 2024, we had two loans totaling $ 191 million on non-accrual status, of which one loan totaling $ 101 million was more than 90 days contractually past due. As of December 31, 2023, we had three loans totaling $ 70 million on non-accrual status. </context> | us-gaap:FinancingReceivableRecordedInvestmentNonaccrualStatus |
We generally place loans on non-accrual status once principal or interest payments are 90 days contractually past due, or earlier if management determines that full collection is not probable. Loans 90 days past due, but considered both well-secured and in the process of collection, may be excluded from non-accrual status. When we place a loan on non-accrual status, the accrual of interest is discontinued and previously recorded but unpaid interest is reversed and generally charged against interest income. For loans on non-accrual status, income is recognized on a cash basis after recovery of principal, if and when interest payments are received. Loans may be removed from non-accrual status when repayment is reasonably assured and performance under the terms of the loan has been demonstrated. As of December 31, 2024, we had two loans totaling $ 191 million on non-accrual status, of which one loan totaling $ 101 million was more than 90 days contractually past due. As of December 31, 2023, we had three loans totaling $ 70 million on non-accrual status. | text | 101 | monetaryItemType | text: <entity> 101 </entity> <entity type> monetaryItemType </entity type> <context> We generally place loans on non-accrual status once principal or interest payments are 90 days contractually past due, or earlier if management determines that full collection is not probable. Loans 90 days past due, but considered both well-secured and in the process of collection, may be excluded from non-accrual status. When we place a loan on non-accrual status, the accrual of interest is discontinued and previously recorded but unpaid interest is reversed and generally charged against interest income. For loans on non-accrual status, income is recognized on a cash basis after recovery of principal, if and when interest payments are received. Loans may be removed from non-accrual status when repayment is reasonably assured and performance under the terms of the loan has been demonstrated. As of December 31, 2024, we had two loans totaling $ 191 million on non-accrual status, of which one loan totaling $ 101 million was more than 90 days contractually past due. As of December 31, 2023, we had three loans totaling $ 70 million on non-accrual status. </context> | us-gaap:FinancingReceivableRecordedInvestmentNonaccrualStatus |
We generally place loans on non-accrual status once principal or interest payments are 90 days contractually past due, or earlier if management determines that full collection is not probable. Loans 90 days past due, but considered both well-secured and in the process of collection, may be excluded from non-accrual status. When we place a loan on non-accrual status, the accrual of interest is discontinued and previously recorded but unpaid interest is reversed and generally charged against interest income. For loans on non-accrual status, income is recognized on a cash basis after recovery of principal, if and when interest payments are received. Loans may be removed from non-accrual status when repayment is reasonably assured and performance under the terms of the loan has been demonstrated. As of December 31, 2024, we had two loans totaling $ 191 million on non-accrual status, of which one loan totaling $ 101 million was more than 90 days contractually past due. As of December 31, 2023, we had three loans totaling $ 70 million on non-accrual status. | text | 70 | monetaryItemType | text: <entity> 70 </entity> <entity type> monetaryItemType </entity type> <context> We generally place loans on non-accrual status once principal or interest payments are 90 days contractually past due, or earlier if management determines that full collection is not probable. Loans 90 days past due, but considered both well-secured and in the process of collection, may be excluded from non-accrual status. When we place a loan on non-accrual status, the accrual of interest is discontinued and previously recorded but unpaid interest is reversed and generally charged against interest income. For loans on non-accrual status, income is recognized on a cash basis after recovery of principal, if and when interest payments are received. Loans may be removed from non-accrual status when repayment is reasonably assured and performance under the terms of the loan has been demonstrated. As of December 31, 2024, we had two loans totaling $ 191 million on non-accrual status, of which one loan totaling $ 101 million was more than 90 days contractually past due. As of December 31, 2023, we had three loans totaling $ 70 million on non-accrual status. </context> | us-gaap:FinancingReceivableRecordedInvestmentNonaccrualStatus |
In 2024, we purchased $ 3.72 billion of collateralized loan obligations in loan form, which were all investment grade as of December 31, 2024. | text | 3.72 | monetaryItemType | text: <entity> 3.72 </entity> <entity type> monetaryItemType </entity type> <context> In 2024, we purchased $ 3.72 billion of collateralized loan obligations in loan form, which were all investment grade as of December 31, 2024. </context> | us-gaap:PaymentsToAcquireLoansReceivable |
We sold $ 300 million of loans in 2024. We recorded a charge-off against the allowance for these loans of $ 37 million in 2024. | text | 300 | monetaryItemType | text: <entity> 300 </entity> <entity type> monetaryItemType </entity type> <context> We sold $ 300 million of loans in 2024. We recorded a charge-off against the allowance for these loans of $ 37 million in 2024. </context> | us-gaap:ProceedsFromSaleOfLoansReceivable |
We sold $ 300 million of loans in 2024. We recorded a charge-off against the allowance for these loans of $ 37 million in 2024. | text | 37 | monetaryItemType | text: <entity> 37 </entity> <entity type> monetaryItemType </entity type> <context> We sold $ 300 million of loans in 2024. We recorded a charge-off against the allowance for these loans of $ 37 million in 2024. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal |
For a financial asset that does not share risk characteristics with other assets, expected credit losses are measured separately using one or more of the methods noted above. As of December 31, 2024, we had 4 loans totaling $ 48 million in the commercial and financial segment and 5 loans totaling $ 402 million in the commercial real estate segment that no longer met the similar risk characteristics of their collective pool. As of December 31, 2024, $ 91 million of our allowance for credit losses was related to these loans. | text | 91 | monetaryItemType | text: <entity> 91 </entity> <entity type> monetaryItemType </entity type> <context> For a financial asset that does not share risk characteristics with other assets, expected credit losses are measured separately using one or more of the methods noted above. As of December 31, 2024, we had 4 loans totaling $ 48 million in the commercial and financial segment and 5 loans totaling $ 402 million in the commercial real estate segment that no longer met the similar risk characteristics of their collective pool. As of December 31, 2024, $ 91 million of our allowance for credit losses was related to these loans. </context> | us-gaap:FinancingReceivableAllowanceForCreditLosses |
Total does not include $ 14 million of loans classified as held-for-sale as of December 31, 2024. | text | 14 | monetaryItemType | text: <entity> 14 </entity> <entity type> monetaryItemType </entity type> <context> Total does not include $ 14 million of loans classified as held-for-sale as of December 31, 2024. </context> | us-gaap:LoansReceivableHeldForSaleAmount |
As of December 31, 2024, accrued interest receivable of $ 327 million included in the amortized cost basis of loans has been excluded from the amortized cost basis within this table. | text | 327 | monetaryItemType | text: <entity> 327 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, accrued interest receivable of $ 327 million included in the amortized cost basis of loans has been excluded from the amortized cost basis within this table. </context> | us-gaap:FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss |
As of December 31, 2023, accrued interest receivable of $ 318 million included in the amortized cost basis of loans has been excluded from the amortized cost basis within this table. | text | 318 | monetaryItemType | text: <entity> 318 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, accrued interest receivable of $ 318 million included in the amortized cost basis of loans has been excluded from the amortized cost basis within this table. </context> | us-gaap:FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss |
Includes $ 3 million allowance for credit losses on Fund Finance loans and $ 1 million on other loans. | text | 3 | monetaryItemType | text: <entity> 3 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 3 million allowance for credit losses on Fund Finance loans and $ 1 million on other loans. </context> | us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest |
Includes $ 3 million allowance for credit losses on Fund Finance loans and $ 1 million on other loans. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> Includes $ 3 million allowance for credit losses on Fund Finance loans and $ 1 million on other loans. </context> | us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest |
Loans are reviewed on a regular basis, and any provisions for credit losses that are recorded reflect management’s estimate of the amount necessary to maintain the allowance for loan losses at a level considered appropriate to absorb expected credit losses in the loan portfolio. In 2024, we recorded a $ 75 million provision for credit losses, primarily reflecting an increase in loan loss reserves associated with certain commercial real estate and leveraged loans, compared to $ 46 million in 2023. Allowance estimates remain subject to continued model and economic uncertainty and management may use qualitative adjustments in the allowance estimates. If future data and forecasts deviate relative to the forecasts utilized to determine our allowance for credit losses as of December 31, 2024, or if credit risk migration is higher or lower than forecasted for reasons independent of the economic forecast, our allowance for credit losses will also change. | text | 75 | monetaryItemType | text: <entity> 75 </entity> <entity type> monetaryItemType </entity type> <context> Loans are reviewed on a regular basis, and any provisions for credit losses that are recorded reflect management’s estimate of the amount necessary to maintain the allowance for loan losses at a level considered appropriate to absorb expected credit losses in the loan portfolio. In 2024, we recorded a $ 75 million provision for credit losses, primarily reflecting an increase in loan loss reserves associated with certain commercial real estate and leveraged loans, compared to $ 46 million in 2023. Allowance estimates remain subject to continued model and economic uncertainty and management may use qualitative adjustments in the allowance estimates. If future data and forecasts deviate relative to the forecasts utilized to determine our allowance for credit losses as of December 31, 2024, or if credit risk migration is higher or lower than forecasted for reasons independent of the economic forecast, our allowance for credit losses will also change. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal |
Loans are reviewed on a regular basis, and any provisions for credit losses that are recorded reflect management’s estimate of the amount necessary to maintain the allowance for loan losses at a level considered appropriate to absorb expected credit losses in the loan portfolio. In 2024, we recorded a $ 75 million provision for credit losses, primarily reflecting an increase in loan loss reserves associated with certain commercial real estate and leveraged loans, compared to $ 46 million in 2023. Allowance estimates remain subject to continued model and economic uncertainty and management may use qualitative adjustments in the allowance estimates. If future data and forecasts deviate relative to the forecasts utilized to determine our allowance for credit losses as of December 31, 2024, or if credit risk migration is higher or lower than forecasted for reasons independent of the economic forecast, our allowance for credit losses will also change. | text | 46 | monetaryItemType | text: <entity> 46 </entity> <entity type> monetaryItemType </entity type> <context> Loans are reviewed on a regular basis, and any provisions for credit losses that are recorded reflect management’s estimate of the amount necessary to maintain the allowance for loan losses at a level considered appropriate to absorb expected credit losses in the loan portfolio. In 2024, we recorded a $ 75 million provision for credit losses, primarily reflecting an increase in loan loss reserves associated with certain commercial real estate and leveraged loans, compared to $ 46 million in 2023. Allowance estimates remain subject to continued model and economic uncertainty and management may use qualitative adjustments in the allowance estimates. If future data and forecasts deviate relative to the forecasts utilized to determine our allowance for credit losses as of December 31, 2024, or if credit risk migration is higher or lower than forecasted for reasons independent of the economic forecast, our allowance for credit losses will also change. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal |
$ 239 million and $ 238 million in 2024, 2023 and 2022, respectively. | text | 239 | monetaryItemType | text: <entity> 239 </entity> <entity type> monetaryItemType </entity type> <context> $ 239 million and $ 238 million in 2024, 2023 and 2022, respectively. </context> | us-gaap:AmortizationOfIntangibleAssets |
$ 239 million and $ 238 million in 2024, 2023 and 2022, respectively. | text | 238 | monetaryItemType | text: <entity> 238 </entity> <entity type> monetaryItemType </entity type> <context> $ 239 million and $ 238 million in 2024, 2023 and 2022, respectively. </context> | us-gaap:AmortizationOfIntangibleAssets |
and $ 183 million as of December 31, 2024 and 2023, respectively. For the year ended December 31, 2024, no | text | 183 | monetaryItemType | text: <entity> 183 </entity> <entity type> monetaryItemType </entity type> <context> and $ 183 million as of December 31, 2024 and 2023, respectively. For the year ended December 31, 2024, no </context> | us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount |
and $ 183 million as of December 31, 2024 and 2023, respectively. For the year ended December 31, 2024, no | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> and $ 183 million as of December 31, 2024 and 2023, respectively. For the year ended December 31, 2024, no </context> | us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.